Currently worldwide, intravitreal injection is the most common treatment for a wide range of retinal diseases. It is a horrifying, painful process that could induce a series of side effects. For most patients, they have to endure monthly, or even weekly injections to effectively treat their disease. Developed by Sonikure Technology aiming to replace needle injections, the Sonikure device safely and efficiently deliver drugs into the eye via our patented low energy and low intensity ultrasonic technology. Compatible to commercial viable eye drugs, the treatment is non-invasive, painless, and proven complication-free in pre-clinical trials.